MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Medical Transcription Billing Corp Company Profile (NASDAQ:MTBC)

Consensus Ratings for Medical Transcription Billing Corp (NASDAQ:MTBC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.63 (305.61% upside)

Analysts' Ratings History for Medical Transcription Billing Corp (NASDAQ:MTBC)
Show:
DateFirmActionRatingPrice TargetActions
2/23/2015Chardan CapitalInitiated CoverageBuy$11.00 -> $6.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014Summer StreetInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2014Chardan CapitalInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2013 forward)